Status:
COMPLETED
Efficacy of SLT in Patients With Insufficient IOP Control Under Maximum Tolerated Drug Therapy (Eye Drops)
Lead Sponsor:
University of Zurich
Collaborating Sponsors:
Ellex Medical Pty, 82 Gilbert Str., Adelaide, SA 5000
Conditions:
Glaucoma
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
Examination and follow-up of efficacy and safety of SLT in patients with unsufficient IOP control despite maximum tolerated topical therapy. In addition, it will be examined whether medical treatment ...
Detailed Description
SLT (Selective Laser Trabeculoplasty) uses the Nd:YAG-Lasers (wavelength 532nm, Q-switched, frequency-doubled). Thanks to the low laser energy used and the short duration of treatment, only pigmented ...
Eligibility Criteria
Inclusion
- Inclusion criteria: Patients with
- primary open angle glaucoma (including normal tension glaucoma)
- pseudoexfoliation glaucoma
- pigment dispersion glaucoma
- Exclusion criteria: previous intraocular surgery closed angle glaucoma pediatric glaucoma inflammatory or uveitic glaucoma unclear view of the trabecular meshwork
Exclusion
Key Trial Info
Start Date :
January 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2009
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT00801658
Start Date
January 1 2008
End Date
July 1 2009
Last Update
December 4 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Zurich, Switzerland